Carcinogenesis in the colon: Interaction between luminal factors and genetic factors

European Journal of Cancer Prevention

Volumn 8, Issue SUPPL. 1, 1999, Pages

  Glinghammar, B ^a   Rafter, J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bile acids; Cell proliferation; Colon cancer; Genes

Indexed keywords

CYCLOOXYGENASE 2; HETEROCYCLIC AMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SHORT CHAIN FATTY ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA;

CANCER EPIDEMIOLOGY; CANCER RISK; COLON CARCINOGENESIS; COLON POLYPOSIS; CONFERENCE PAPER; DIET; GENE EXPRESSION; GENETIC ANALYSIS; LIPID METABOLISM; MOLECULAR BIOLOGY; PRIORITY JOURNAL;

ANIMALS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLONIC NEOPLASMS; DIETARY FATS; FEMALE; GENE EXPRESSION; GENES, APC; HUMANS; LIPID METABOLISM; MALE; MOLECULAR BIOLOGY; RISK ASSESSMENT; TRANSCRIPTION, GENETIC;

EID: 0033497825     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. Angel P, Karin M (1991). The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation Biochim Biophys Acta 10: 129-57.
2. Angel P, Baumann I, Stein B et al. (1987). 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol Cell Biol 7: 2256-66.
3. Barnard JA, Warwick G (1993). Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells Cell Growth Differ 4: 495-501.
4. Bry L, Falk PG, Midtvedt T et al. (1996). A model of host-microbial interactions in an open mammalian ecosystem. Science 273: 1380-3.
5. DuBois RN, Giardiello FM, Smalley WE (1996). Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention Gastroenterol Clin North Am 25: 773-91.
6. Dong QG, Gong LL, Wang HJ et al. (1993). Isolation of a mitomycin-resistant human lung adenocarcinoma cell subline to investigate the modulation by sodium butyrate of cell growth and drug resistance. Anticancer Drugs 4: 617-27.
7. Dulic V, Kaufmann WK, Wilson SJ et al (1994). p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-23.
8. el-Deiry WS, Tokino T, Velculescu VE et al. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-25.
9. Fearon ER, Vogelstein B (1990). A genetic model for colorectal tumorigenesis. Science 247: 49-56.
10. Glinghammar B, Holmberg K, Rafter J (1999). Effects of colonic lumenal components on AP-1 dependent gene transcription in cultured human colon carcinoma cells. Carcinogenesis 20: 969-76.
11. Gould KA, Dove WF (1996). Action of Min and Moml on neoplasia in ectopic intestinal grafts. Cell Growth Differ 7: 1361-8.
12. Gu Y, Turck CW, Morgan DO (1993). Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707-10.
13. Hague A, Elder DJ, Hicks DJ et al. (1995). Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer 60: 400-6.
14. Hague A, Diaz GD, Hicks DJ et al. (1997). bcl-2 and bak may play a pivotal role in sodium butyrate-induced apoptosis in colonic epithelial cells; however overexpression of bcl-2 does not protect against bak-mediated apoptosis. Int J Cancer 72: 898-905.
15. Harwig SS, Tan L, Qu XD et al. (1995). Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest 95: 603-10.
16. Hassig CA, Tong JK, Schreiber SL (1997). Fiber-derived butyrate and the prevention of colon cancer. Chem Biol 4: 783-9.
17. Herold KM, Rothberg PG (1988). Evidence for a labile intermediate in the butyrate induced reduction of the level of c-myc RNA in SW837 rectal carcinoma cells. Oncogene 3: 423-8.
18. Hirano F, Tanada H, Makino Y et al. (1996). Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids. Carcinogenesis 17: 427-33.
19. Hodin RA, Meng S, Archer S et al. (1996). Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells. Cell Growth Differ 7: 647-53.
20. Huang C, Ma WY, Dawson MI et al. (1997). Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc Natl Acad Sci USA 94: 5826-30.
21. Hursting SD (1997). Experimental models of gene-environment interaction for cancer chemoprevention studies. Curr Opin Oncol 9: 487-91.
22. Inoue H, Yokoyama C, Hara S et al. (1996). Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J Biol Chem 270: 24965-71.
23. Kakiuchi H, Ushijima T, Ochiai M et al. (1993). Rare frequency of activation of the Ki-ras gene in rat colon tumors induced by heterocyclic amines: possible alternative mechanisms of human colon carcinogenesis. Mol Carcinog 8: 44-8.
24. Kakiuchi H, Watanabe M, Ushijima T et al. (1995). Specific 5′-GGGA-3′ → 5′-GGA-3′ mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc Natl Acad Sci USA 92: 910-4.
25. Kinzler KW, Vogelstein B (1996). Lessons from hereditary colorectal cancer. Cell 87:159-70.
26. Kuiper GG, Enmark E, Pelto-Huikko M et al. (1996). Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-30.
27. Lefebvre AM, Chen I, Desreumaux P et al. (1998). Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med 4:1053-7.
28. Li CY, Suardet L, Little JB (1995). Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect. J Biol Chem 270: 4971-4.
29. MacPhee M, Chepenik KP, Liddell RA et al. (1995). The secretory phospholipase A2 gene is a candidate for the Moml locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell 81: 957-66.
30. Makino H, Ushijima T, Kakiuchi H et al. (1994). Absence of p53 mutations in rat colon tumors induced by 2-amino-6-methyldipyrido[1,2-a:3′,2′-d]imidazole, 2-amino-3-methylimidazo[4,5-f]quinoline, or 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn J Cancer Res 85: 510-4.
31. Matheson H, Branting C, Rafter I et al. (1996). Increased c-fos mRNA and binding to the AP-1 recognition sequence accompanies the proliferative response to deoxycholate of HT29 cells. Carcinogenesis 17: 421-6.
32. Nishizuka Y (1995). Protein kinase C and lipid signalling for sustained cellular responses. FASEB J 9: 484-96.
33. Oshima M, Oshima H, Kitagawa K et al. (1995). Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci USA 92: 4482-6.
34. Oshima M, Dinchuk JE, Kargman SL et al. (1996a). Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-9.
35. Oshima M, Oshima H, Tsutsumi M et al. (1996b). Effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine on intestinal polyp development in Apc delta 716 knockout mice. Mol Carcinog 15: 11-7.
36. Palmer DG, Paraskeva C, Williams AC (1997). Modulation of p53 expression in cultured colonic adenoma cell lines by the naturally occurring luminal factors butyrate and deoxycholate. Int J Cancer 73: 702-6.
37. Pedraza-Alva C, Zingg JM, Jost JP (1994). AP-1 binds to a putative cAMP response element of the MyoD1 promoter and negatively modulates MyoD1 expression in dividing myoblasts. J Biol Chem 269:6978-85.
38. Pritchard DM, Watson AJM (1996). Apoptosis and gastro-intestinal pharmacology. Pharmacol Ther 72: 149-69.
39. Register TC, O'Sullivan MG (1998). In 80th Annual Meeting of the Endocrine Society, New Orleans, Louisiana, USA (Abstract).
40. Saez E, Tontonoz P, Nelson MC et al. (1998). Activators of the nuclear receptor PPARgamma enhance colon polyp formation. Nat Med 4: 1058-61.
41. Saito H, Morizane T, Watanabe T et al. (1991). Differentiating effect of sodium butyrate on human hepatoma cell lines PLC/PRF/5, HCC-M and HCC-T. Int J Cancer 48: 291-6.
42. Sarraf P, Mueller E, Jones D et al. (1998). Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat Med 4: 1046-52.
43. Sinicrope FA, Roddey G, McDonnell TJ et al. (1996). Increased Apoptosis Accompanies Neoplastic Development in the Human Colorectum. Clin Cancer Res 2: 1999-2006.
44. Vogelstein B, Fearon ER, Hamilton SR et al. (1988). Genetic alterations during colorectal-tumor development. N Eng J Med 319: 525-32.
45. Wang CY, Eshleman JR, Willson JK et al. (1995). Both transforming growth factor-beta and substrate release are inducers of apoptosis in a human colon adenoma cell line. Cancer Res 55: 5101-5.
46. Wang J, Friedman EA (1998). Short-chain fatty acids induce cell cycle inhibitors in colonocytes. Gastroenterology 114: 940-6.
47. Xie W, Herschman HR (1995). v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J Biol Chem 270: 27622-8.
48. Zhang F, Subbaramaiah K, Altorki, N et al. (1998). Dihydroxy bile acids activate the transcription of cyclooxygenase-2. J Biol Chem 273: 2424-8.